Literature DB >> 4716180

Platelet aggregation inhibitors. 4. N 6 -substituted adenosines.

K Kikugawa, K Iizuka, M Ichino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4716180     DOI: 10.1021/jm00262a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  7 in total

1.  Anticytokinin activity of substituted pyrrolo[2,3-d]pyrimidines.

Authors:  F Skoog; R Y Schmitz; S M Hecht; R B Frye
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

2.  Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates.

Authors:  K Shah; Y Liu; C Deirmengian; K M Shokat
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.

Authors:  R J Haslam; M M Davidson; J V Desjardins
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

4.  Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.

Authors:  J W Daly; P Butts-Lamb; W Padgett
Journal:  Cell Mol Neurobiol       Date:  1983-03       Impact factor: 5.046

5.  5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1981-03       Impact factor: 8.739

6.  Functionalized congeners of adenosine: preparation of analogues with high affinity for A1-adenosine receptors.

Authors:  K A Jacobson; K L Kirk; W L Padgett; J W Daly
Journal:  J Med Chem       Date:  1985-09       Impact factor: 7.446

7.  A semisynthetic epitope for kinase substrates.

Authors:  Jasmina J Allen; Manqing Li; Craig S Brinkworth; Jennifer L Paulson; Dan Wang; Anette Hübner; Wen-Hai Chou; Roger J Davis; Alma L Burlingame; Robert O Messing; Carol D Katayama; Stephen M Hedrick; Kevan M Shokat
Journal:  Nat Methods       Date:  2007-05-07       Impact factor: 28.547

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.